Literature DB >> 18274079

Recent advances in breast cancer genetics.

Boris Pasche1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18274079      PMCID： PMC2637546          DOI： 10.1007/978-0-387-73161-2_1

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  40 in total

1.  Polygenic susceptibility to breast cancer and implications for prevention.

Authors:  Paul D P Pharoah; Antonis Antoniou; Martin Bobrow; Ron L Zimmern; Douglas F Easton; Bruce A J Ponder
Journal:  Nat Genet       Date:  2002-03-04       Impact factor: 38.330

2.  Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer.

Authors:  Simon W Baxter; David Y H Choong; Diana M Eccles; Ian G Campbell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-02       Impact factor: 4.254

Review 3.  Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage.

Authors:  Kiyotsugu Yoshida; Yoshio Miki
Journal:  Cancer Sci       Date:  2004-11       Impact factor: 6.716

4.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

5.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

Authors:  L C Hartmann; T A Sellers; D J Schaid; T S Frank; C L Soderberg; D L Sitta; M H Frost; C S Grant; J H Donohue; J E Woods; S K McDonnell; C W Vockley; A Deffenbaugh; F J Couch; R B Jenkins
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

6.  Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

Authors:  S A Narod; J S Brunet; P Ghadirian; M Robson; K Heimdal; S L Neuhausen; D Stoppa-Lyonnet; C Lerman; B Pasini; P de los Rios; B Weber; H Lynch
Journal:  Lancet       Date:  2000-12-02       Impact factor: 79.321

7.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Authors:  Donald A Berry; Edwin S Iversen; Daniel F Gudbjartsson; Elaine H Hiller; Judy E Garber; Beth N Peshkin; Caryn Lerman; Patrice Watson; Henry T Lynch; Susan G Hilsenbeck; Wendy S Rubinstein; Kevin S Hughes; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

8.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

9.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

Authors:  Timothy R Rebbeck; Henry T Lynch; Susan L Neuhausen; Steven A Narod; Laura Van't Veer; Judy E Garber; Gareth Evans; Claudine Isaacs; Mary B Daly; Ellen Matloff; Olufunmilayo I Olopade; Barbara L Weber
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

10.  Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Authors:  Thomas S Frank; Amie M Deffenbaugh; Julia E Reid; Mark Hulick; Brian E Ward; Beth Lingenfelter; Kathi L Gumpper; Thomas Scholl; Sean V Tavtigian; Dmitry R Pruss; Gregory C Critchfield
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544
View more
  6 in total

1.  Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.

Authors:  Da Pang; Yashuang Zhao; Weinan Xue; Ming Shan; Yanbo Chen; Youxue Zhang; Guoqiang Zhang; Feng Liu; Dalin Li; Yanmei Yang
Journal:  Med Oncol       Date:  2011-11-11       Impact factor: 3.064

Review 2.  TGFBR1 signaling and breast cancer.

Authors:  Lakisha Moore-Smith; Boris Pasche
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-04-05       Impact factor: 2.673

Review 3.  RAP80, ubiquitin and SUMO in the DNA damage response.

Authors:  Patrick M Lombardi; Michael J Matunis; Cynthia Wolberger
Journal:  J Mol Med (Berl)       Date:  2017-07-05       Impact factor: 4.599

4.  Biological processes, properties and molecular wiring diagrams of candidate low-penetrance breast cancer susceptibility genes.

Authors:  Núria Bonifaci; Antoni Berenguer; Javier Díez; Oscar Reina; Ignacio Medina; Joaquín Dopazo; Víctor Moreno; Miguel Angel Pujana
Journal:  BMC Med Genomics       Date:  2008-12-18       Impact factor: 3.063

5.  The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women.

Authors:  Peijian Ding; Yang Yang; Luyang Cheng; Xuejun Zhang; Limin Cheng; Caizhen Li; Jianhui Cai
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

6.  Screening, diagnosis and genetic study of breast cancer patients in Pakistan.

Authors:  Ayesha Isani Majeed; Asmat Ullah; Muniba Jadoon; Wasim Ahmad; Sheikh Riazuddin
Journal:  Pak J Med Sci       Date:  2020 Jan-Feb       Impact factor: 1.088
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.